Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 21: Vascular Diseases & Diabetic Retinopathy IV

12:30 - 14:00 | 08 September | Room: Amphitheatre Havane

Back to Previous

12:30The effect of duration on retinal and choroidal thicknesses in children with hypertension
S. Karaman Erdur Turkey
12:36Results of a phase 1, open-label, dose-escalation study of THR-149 in patients with diabetic macular oedema (DME)
P. Dugel United States
12:42Smartphone-based fundus imaging in diabetic retinopathy screening in low- and middle-income countries: Evaluation of four different devices
M. Wintergerst Germany
12:48Social deprivation as a risk factor for the incidence of retinal vein occlusion
T. Mahendiran United Kingdom
12:54Spectral domain optical coherence tomography (SD-OCT) based morphometric response of intravitreal dexamethasone implant for diabetic macular edema (DME)
P. Bodhankar India
13:00Spectral-domain optical coherence tomography-driven treat-and-extend regimen in patients with diabetic macular edema: 24-Month evaluation and outcome predictors
K. Hatz Switzerland
13:06Surgical treatment of diabetic maculopathy in patients with type 2 diabetes mellitus: long-term results
I. Panchenko Ukraine
13:12System of classification and automatic reference of diabetic retinopathy based on artificial intelligence in developing countries
J. Valdez Lopez Mexico
13:18Ten-year incidence and progression of diabetic retinopathy in type 1 and type 2 diabetes mellitus in France and its impact on screening strategy: the OPHDIAT study A retrospective study based on a screening program
C. Chamard France
13:24Ten-year outcomes of conventional panretinal photocoagulation in eyes with proliferative diabetic retinopathy
V. Rajendran India
13:30Treat and extend protocol with aflibercept for cystoid macular edema secondary to central retinal vein occlusion – an 18-month prospective cohort study
R. O'Day United Kingdom
13:36Treatment of diabetic macular oedema: real world outcomes from a dedicated UK injection unit
E. Linton United Kingdom
13:42Treatment outcomes achieved with the intravitreal 0.19 mg fluocinolone acetonide implant in clinical practices - Interim results from the prospective IDEAL registry study in Germany
R. Khoramnia Germany
13:48Two-year treatment outcomes of subthreshold micropulse yellow (577 nm) laser for diabetic macular edema
H. Lai Hong Kong
Back to Previous

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved